VCAN and non-small cell lung carcinoma: Our findings indicated that versican was highly expressed in plasma and plasma exosomes from NSCLC patients, and that this expression was significantly associated with the clinicopathological features of lymph node metastasis and distal metastasis in NSCLC patients, as well as with the presence of a mutation.